Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 3, 1997, Pages 493-498

  Velíšek, Libor ^a,b   Vachová, Dana ^a   Mareš, Pavel ^a,b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

amino acid; antagonist; CGP 39551; ontogenesis; seizures

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; ANTICONVULSIVE AGENT; EXCITATORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANTICONVULSANTS; CONVULSANTS; DRUG EVALUATION, PRECLINICAL; EPILEPSY, TONIC-CLONIC; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 19244378718     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00245-6     Document Type: Article

References (45)

1. Browning, R. A. Role of the brain-stem reticular formation in tonic-clonic seizures: Lesion and pharmacological studies. Fed. Proc. 44:2425-31; 1985.
2. Browning, R. A.; Nelson, D. K. Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp. Neurol. 93:546-556; 1986.
3. Chapman, A. G.; Graham, J. L.; Patel, S.; Meldrum, B. S. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Epilepsia 32:578-587; 1991.
4. Collingridge, G. L.; Lester, R. A. J. Excitatory amino acid receptors in the vertebrate nervous system. Pharmacol. Rev. 40:143-210; 1989.
5. Croucher, M. J.; Collins, J. F.; Meldrum, B. S. Anticonvulsant action of excitatory amino acid antagonists. Science 899-901; 1982.
6. Czuczwar, S. J.; Frey, H.-H.; Löscher, W. Antagonism of N-methyl-D-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur. J. Pharmacol. 108:273-280; 1985.
7. De Sarro, G. B.; Meldrum, B.; Reaville, C. Anticonvulsant action of 2-amino-7 phosphonoheptanoic acid in the substantia nigra. Eur. J. Pharmacol. 106:175-179; 1984.
8. Dingledine, R.; McBain, C. J.; McNamara, J. O. Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11:334-338; 1990.
9. Ellison, G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res. Rev. 20:250-267; 1995.
10. Fagg, G.; Foster, A.; Ganong, A. Excitatory amino acid synaptic mechanism and neurological function. Trends Pharmacol. Sci. 7:357-363; 1986.
11. Fisher, R. S. Animal models of epilepsies. Brain Res. Rev. 14:245-278; 1989.
12. Gale, K. Progression and generalization of seizure discharge: Anatomical and neurochemical substrates. Epilepsia 29 (Suppl 2):S15-S34; 1988.
13. Gottlieb, A.; Keydor, I.; Epstein, H. T. Rodent brain growth stages. An analytical review. Biol. Neonate 32:166-176; 1977.
14. Hansen, J. J.; Krogsgaard-Larsen, P. Structural, conformational and stereochemical requirements of central excitatory amino acid receptors. Med. Res. Rev. 10:55-94; 1990.
15. Hayes, B. A.; Balster, R. L. Anticonvulsant properties of phencyclidine-like drugs in mice. Eur. J. Pharmacol. 117:121-125; 1985.
16. Insel, T. R.; Miller, R. P.; Gelhard, R. E. The ontogeny of excitatory amino acid receptors in rat forebrain - I. N-methyl-D-aspartate receptors and quisqualate receptors. Neuroscience 35:31-43; 1990.
17. Johnston, G. A. R. Convulsions induced in 10-day-old rats by intraperitoneal injection of monosodium glutamate. Biochem. Pharmacol. 22:137-140; 1973.
18. Löscher, W.; Schmidt, D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:145-181; 1988.
19. Mareš, P.; Velíšek, L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Dev. Brain Res. 65:185-189; 1992.
20. Mareš, P.; Zouhar, A. Do we possess adequate models of childhood epilepsies. Physiol. Bohemoslov. 37:1-9; 1988.
21. Meldrum, B. S. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68:113-122; 1985.
22. Meldrum, B. S. Excitatory amino acids and epilepsy. In: Hicks, T. P.; Lodge, D.; McLennan, H., eds. Excitatory amino acid transmission. New York: Alan R Liss; 1987:189-196.
23. Meldrum, B. S. Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res. 12:189-196; 1992.
24. Meldrum,B. S.; Croucher, M. J.; Badman, G.; Collins, J. F. Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci. Lett. 39:101-104; 1983.
25. Morris, R. G. M.; Anderson, E.; Lynch, G. S.; Baudry, M. Selective impairment of learning and blockade of LTP by an NMDA receptor antagonist AP5. Nature 319:774-775; 1986.
26. Myslobodsky, M. S.; Golovchinsky, V.; Mintz, M. Ketamine: Convulsant or anticonvulsant? Pharmacol. Biochem. Behav. 14:27-33; 1981.
27. Piredda, S.; Gale, K. A crucial epileptogenic site in the deep prepiriform cortex. Science 317:623-625; 1985.
28. Pohl, M.; Mareš, P. Effects of flunarizine on Metrazol-induced seizures in developing rats. Epilepsy Res. 1:302-305; 1987.
29. Schoepp, D. D.; Gamble, A. Y.; Salhoff, C. R.; Johnson, B. G.; Ornstein, P. L. Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. Eur. J. Pharmacol. 182:421-427; 1990.
30. Smith, S. E.; Durmuller, N.; Meldrum, B. S. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 201:179-183; 1991.
31. Swann, J. W. Synaptogenesis and epileptogenesis in developing neural networks. In: Schwartzkroin, P. A.; Moshé, S. L.; Noebels, J. L.; Swann, J. W., eds. Brain development and epilepsy. New York: Oxford University Press; 1995:195-233.
32. Taberner, P. V. The anticonvulsant activity of ketamine against seizures induced by pentylenetetrazol and mercaptopropionic acid. Eur. J. Pharmacol. 39:305-311; 1975.
33. Troupin, A. S.; Mendius, J. R.; Cheng, F.; Risinger, M. W. MK-801. In: Meldrum, B. S.; Porter, R. J., eds. New anticonvulsant drugs. London: John Libbey; 1986:191-201.
34. Tsumoto, T.; Hagihara, H.; Sato, H.; Hata, S. NMDA receptors in the visual cortex of young kittens are more effective than those of adult cats. Nature 327:513-514; 1987.
35. Velíšek, L.; Kubová, H.; Pohl, M.; Staňková, L.; Mareš, P.; Schickerová, R. Pentylenetetrazol-induced seizures in rats: An ontogenetic study. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:588-591; 1992.
36. Velíšek, L.; Kusá, R.; Kulovaná, M.; Mareš, P. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: I. The effects of 2-amino-7-phosphonoheptanoate. Life Sci. 46:1349-1357; 1990.
37. Velíšek, L.; Mareš, P. Developmental aspects of the anticonvulsant action of MK-801. In: Kamenka, J.-M.; Domino, E. F., eds. Multiple sigma and PCP receptor ligands: Mechanisms for neuromodulation and neuroprotection? Ann Arbor: NPP Books; 1992:779-795.
38. Velíšek, L.; Mikolášová, R.; Mareš, P. Effects of ketamine on metrazol-induced seizures during ontogenesis in rats. Pharmacol. Biochem. Behav. 32:405-410; 1989.
39. Velíšek, L.; Roztočilová, L.; Kusá, R.; Mareš, P. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: III. Effects of kynurenic acid and glutamic acid diethylester. Brain Res. Bull. 38:525-529; 1995.
40. Velíšek, L.; Verešová, S.; Pôbišová, H.; Mareš , P. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: II. The effects of MK-801. Psychopharmacology 104:510-514; 1991.
41. Velíšková, J.; Velíšek, L. Picrotoxin-induced tonic-clonic seizures and lethality are decreased by MK-801 hi developing rats. Pharmacol. Biochem. Behav. 43:291-295; 1992.
42. Velíšková, J.; Velíšek, L.; Mareš, P.; Rokyta, R. Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis. Pharmacol. Biochem. Behav. 37:667-674; 1990.
43. Vernadakis, A.; Woodbury, D. M. The developing animal as a model. Epilepsia 10:163-178; 1969.
44. Watkins, J. C.; Olverman, H. J. Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci. 10:265-272; 1987.
45. Zaczek, R.; Coyle, J. T. Excitatory amino acid analogues: Neurotoxicity and seizures. Neuropharmacology 21:15-26; 1982.